Evidence map›Paper›PMID 34150923›Full record

ArticleOpen forum infectious diseases2019

Rapid, Sample-to-Answer Host Gene Expression Test to Diagnose Viral Infection.

Ephraim L Tsalik, Ayeaye Khine, Abdossamad Talebpour, Alaleh Samiei, Vilcy Parmar, Thomas W Burke, Micah T Mcclain, Geoffrey S Ginsburg, Christopher W Woods, Ricardo Henao and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00258869 (Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00258869 unknown statusnot on this map

Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP

TypeobservationalSponsorNational Center for Genome ResourcesRan2005 to 2010Enrolled1,200ConditionsSepsis, Septicemia, Sepsis Syndrome, Shock, Septic
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
  6. Article
  7. Article
  8. A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states.Translational research : the journal of laboratory and clinical medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ephraim L TsalikDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Ayeaye KhineQvella Corporation, Richmond Hill, Ontario, Canada.
Abdossamad TalebpourQvella Corporation, Richmond Hill, Ontario, Canada.
Alaleh SamieiQvella Corporation, Richmond Hill, Ontario, Canada.
Vilcy ParmarQvella Corporation, Richmond Hill, Ontario, Canada.
Thomas W BurkeDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Micah T McclainDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Geoffrey S GinsburgDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Christopher W WoodsDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Ricardo HenaoDuke Center for Applied Genomics and Precision Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Tino AlavieQvella Corporation, Richmond Hill, Ontario, Canada.
Dalsa Corporation · CADuke University · USDurham VA Health Care System · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

objectiveDistinguishing bacterial, viral, or other etiologies of acute illness is diagnostically challenging with significant implications for appropriate antimicrobial use. Host gene expression offers a promising approach, although no clinically useful test has been developed yet to accomplish this. Here, Qvella's FAST HR (Richmond Hill, Ontario, Canada) process was developed to quantify previously identified host gene expression signatures in whole blood in <45 minutes.

methodWhole blood was collected from 128 human subjects (mean age 47, range 18-88) with clinically adjudicated, microbiologically confirmed viral infection, bacterial infection, noninfectious illness, or healthy controls. Stabilized mRNA was released from cleaned and stabilized RNA-surfactant complexes using e-lysis, an electrical process providing a quantitative real-time reverse transcription polymerase chain reaction-ready sample. Threshold cycle values (C

resultsReproducibility of mRNA quantification was within 1 cycle as compared to the difference seen between subjects with viral versus nonviral infection (up to 5.0 normalized C

conclusionsThese results demonstrate the ability to translate host gene expression signatures to clinical platforms for use in patients with suspected infection. CLINICAL TRIALS REGISTRATION: NCT00258869.

Indexed as

gene expression profilinginfectionmolecular diagnostic techniquesreal-time polymerase chain reactionvirus diseases

Identifiers

PMID34150923
PMCPMC8210837
OpenAlexW2982430379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.